Press Release Archives
-
Which Drug Delivery Technologies Should You Know About in 2024
Adare’s Srinivasan Shanmugam recently delivered an insightful tech talk at the Fierce Pharma Forward virtual event, titled "Latest in Multiparticulate Drug Delivery for Pediatric and Geriatric Population Patients." In this compelling... Learn More
-
Customized Release Through Dispersed Dosage Formats Driving Patient Acceptance and Therapeutic Performance
Pharmaceutical development is as much an art as it is a science, with experts working to find the best solutions and then formulating them in a manner that is universally accessible, efficacious, and sustainable. This balance is... Learn More
-
Watch Now: The Importance Of An End-To-End CDMO
In this presentation, Adare Vice President of Business Development Strategic Accounts Uli Foley discusses the importance of working with a CDMO that provides services at every step of the commercialization journey. An outsourcing... Learn More
-
From Risk To Resolution: A Breakthrough in Nitrosamine Analysis & Mitigation
Since the release of the FDA’s guidance on Nitrosamine Drug Substance-Related Impurities (NDSRIs), the pharmaceutical industry has been diligently attempting to identify at-risk APIs, update risk assessments, and devise control... Learn More
-
Adare Expands Global High Potency Handling & Packaging Capabilities
LAWRENCEVILLE, N.J., May 1, 2024 -- Adare Pharma Solutions, a global technology-driven CDMO specializing in oral dosage forms, today announced expansions of its high potency handling capabilities in the United States and Europe. In the... Learn More
-
Adare Pharma Solutions Expanding Oral Dose Capabilities In Europe
LAWRENCEVILLE, NJ, March 12, 2024 -- Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced it is further investing in its Pessano facility in Milan, Italy, with the addition of a high-shear... Learn More
-
Adare Pharma Solutions To Expand Packaging & Warehousing Capabilities In Europe
LAWRENCEVILLE, NJ, March 5, 2024 -- Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced that work has begun to add packaging capabilities and further warehousing capacity at its Pessano... Learn More
-
Adare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenich
PHILADELPHIA, Pennsylvania, July 3, 2023 — Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced the completion of its divestiture of its Adare Biome business unit, a pioneer in the... Learn More
-
Meet The Experts Networking Tour 2023
Our Meet The Experts networking tour has stops across the country this summer. Come join us for happy hour and learn more about Adare straight from the experts! Let's get together and talk about how we can put our unparalleled... Learn More
-
DSM agrees to terms to acquire postbiotics pioneer Adare Biome
HEERLEN, Netherlands — April 19, 2023 Royal DSM, a global science-based leader in health, nutrition and bioscience, announces that it has entered into exclusive negotiations with Adare Pharma Solutions in order to acquire Adare Biome,... Learn More
